Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shmeylan Al Harbi

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 20, 2006
Pharmacists' attitudes toward ACLS provider training programShmeylan Al Harbi, Donald Miller
Saudi Journal of Ophthalmology : Official Journal of the Saudi Ophthalmological Society|June 1, 2017
Topical versus subconjunctival anti-vascular endothelial growth factor therapy (Bevacizumab, Ranibizumab and Aflibercept) for treatment of corneal neovascularizationTariq Al-Debasi, Abdulkareem Al-Bekairy, Abdulmalik Al-Katheri, et al.
Idcases|July 20, 2022
A case report on the association between QTc prolongation and remdesivir therapy in a critically ill patientShmeylan Al Harbi, Mashael AlFaifi, Hasan M Al-Dorzi, et al.
Saudi Journal of Medicine & Medical Sciences|October 30, 2025
Barriers to Rapid Stroke Thrombolysis at a Large Tertiary Care Hospital in Riyadh, Saudi ArabiaMohammed Alrashed, Layan Alarifi, Ahlam Almutairi, et al.
Saudi Journal of Anaesthesia|October 17, 2017
Assessment of patient-controlled analgesia versus intermittent opioid therapy to manage sickle-cell disease vaso-occlusive crisis in adult patientsAlaa Al-Anazi, Lowloa Al-Swaidan, Maha Al-Ammari, et al.
BMC Infectious Diseases|November 25, 2021
The impact of early target attainment of vancomycin in critically ill patients with confirmed Gram-positive infection: A retrospective cohort studyKhalid Al Sulaiman, Abdulrahman Alshaya, Ohoud Aljuhani, et al.
Nanotechnology, Science and Applications|December 15, 2025
Polymer-Lipid Hybrid Nanoparticles for Enhanced Gentamicin Efficacy Against Drug-Resistant BacteriaAlaa Eldeen Yassin, Faisal Alsuwayyid, Lama Alkhathran, et al.
Frontiers in Medicine|May 25, 2026
Fondaparinux versus argatroban for the management of suspected or confirmed heparin-induced thrombocytopenia: a propensity score-matched cohort studyLama Alfehaid, Khalid Al Sulaiman, Abdulmajeed M Alshehri, et al.
Critical Care (London, England)|October 19, 2021
Evaluation of zinc sulfate as an adjunctive therapy in COVID-19 critically ill patients: a two center propensity-score matched studyKhalid Al Sulaiman, Ohoud Aljuhani, Abdulrahman I Al Shaya, et al.
Journal of Clinical Medicine|November 9, 2024
Impact of Hyperuricemia on Clinical Outcomes in Sepsis Patients: A Retrospective Cohort StudyAbdulmajeed M Alshehri, Mohammed Alrashed, Mohammad Shawaqfeh, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 20, 2006
Pharmacists' attitudes toward ACLS provider training programShmeylan Al Harbi, Donald Miller
Saudi Journal of Ophthalmology : Official Journal of the Saudi Ophthalmological Society|June 1, 2017
Topical versus subconjunctival anti-vascular endothelial growth factor therapy (Bevacizumab, Ranibizumab and Aflibercept) for treatment of corneal neovascularizationTariq Al-Debasi, Abdulkareem Al-Bekairy, Abdulmalik Al-Katheri, et al.
Idcases|July 20, 2022
A case report on the association between QTc prolongation and remdesivir therapy in a critically ill patientShmeylan Al Harbi, Mashael AlFaifi, Hasan M Al-Dorzi, et al.
Saudi Journal of Medicine & Medical Sciences|October 30, 2025
Barriers to Rapid Stroke Thrombolysis at a Large Tertiary Care Hospital in Riyadh, Saudi ArabiaMohammed Alrashed, Layan Alarifi, Ahlam Almutairi, et al.
Saudi Journal of Anaesthesia|October 17, 2017
Assessment of patient-controlled analgesia versus intermittent opioid therapy to manage sickle-cell disease vaso-occlusive crisis in adult patientsAlaa Al-Anazi, Lowloa Al-Swaidan, Maha Al-Ammari, et al.
BMC Infectious Diseases|November 25, 2021
The impact of early target attainment of vancomycin in critically ill patients with confirmed Gram-positive infection: A retrospective cohort studyKhalid Al Sulaiman, Abdulrahman Alshaya, Ohoud Aljuhani, et al.
Nanotechnology, Science and Applications|December 15, 2025
Polymer-Lipid Hybrid Nanoparticles for Enhanced Gentamicin Efficacy Against Drug-Resistant BacteriaAlaa Eldeen Yassin, Faisal Alsuwayyid, Lama Alkhathran, et al.
Frontiers in Medicine|May 25, 2026
Fondaparinux versus argatroban for the management of suspected or confirmed heparin-induced thrombocytopenia: a propensity score-matched cohort studyLama Alfehaid, Khalid Al Sulaiman, Abdulmajeed M Alshehri, et al.
Critical Care (London, England)|October 19, 2021
Evaluation of zinc sulfate as an adjunctive therapy in COVID-19 critically ill patients: a two center propensity-score matched studyKhalid Al Sulaiman, Ohoud Aljuhani, Abdulrahman I Al Shaya, et al.
Journal of Clinical Medicine|November 9, 2024
Impact of Hyperuricemia on Clinical Outcomes in Sepsis Patients: A Retrospective Cohort StudyAbdulmajeed M Alshehri, Mohammed Alrashed, Mohammad Shawaqfeh, et al.
Pageof 4